Health Care Costs: Why Providers, Not Insurers, Dominate the Equation

The United States spends nearly 18% of its GDP on health care, more than any other OECD country, yet it ranks poorly on health outcomes. Many attribute high costs to insurance premiums, but evidence shows that provider practices are the main culprits.

A pivotal study published in Health Affairs in May 2023 examined hospital spending across 15 U.S. metropolitan areas. Researchers found that pricing variations for identical procedures, such as knee replacements and colonoscopies, account for the largest disparities in regional health expenditures. "It’s not the volume of services that’s bankrupting the system," explained Dr. Miriam Keller, a health economist at Johns Hopkins University. "It’s the unit price."

This aligns with findings from a 2021 RAND Corporation report, which tracked payments made by private insurers to hospitals nationwide. RAND's analysis revealed that private insurers paid, on average, 224% of what Medicare reimbursed for identical services in 2021, up from 190% in 2016. This widening gap suggests that provider consolidation enables hospitals to exert oligopolistic pricing power.

The American Hospital Association contested RAND's conclusions, emphasizing the operational challenges faced by large hospitals. However, health policy experts argue these challenges often prioritize capital expenditures—like high-end surgical suites—over affordable care delivery.

According to a 2022 JAMA study, hospital mergers and acquisitions have accelerated in recent decades. Over 70% of U.S. hospitals now belong to a system, compared to 50% in 2000. "When five systems control 85% of beds in a metro area, you end up with what economists term 'price insensitivity,'" said Dr. Kenji Nakamura of Stanford University. "Patients and insurers alike lose bargaining power."

Insurers often face criticism for high premiums and opaque pricing. Yet, their administrative costs, while higher than those in single-payer systems like the UK’s NHS, comprise only 8-12% of total U.S. health spending. In contrast, professional services—including physician fees—account for over 60%.

"It’s tempting to vilify insurers," said Karen Rosenblatt, chief analyst at HealthInsight Partners. "But insurers act as intermediaries; they don’t dictate the $100 aspirin or the $50,000 vaginal delivery." She acknowledges that insurers' willingness to reimburse inflated charges perpetuates the cycle. "It’s a cycle of complicity," she noted.

The Affordable Care Act (ACA), signed into law in 2010, aimed to tackle provider-driven inflation by expanding coverage and mandating price transparency. However, compliance remains inconsistent. In 2022, the Centers for Medicare and Medicaid Services penalized just two hospitals for noncompliance under its price transparency rule, out of over 6,000.

Proponents of Medicare for All argue that a single-payer system would force providers to standardize pricing. Critics contend this might lead to rationing of care or disincentivize innovation. Experience from Germany, which employs an all-payer system, suggests that collective negotiation with providers can cap costs while preserving private sector participation.

Countries that outperform the U.S. in cost-efficiency, such as Australia and Switzerland, enforce limits on provider pricing. "The U.S. approach to health care is uniquely laissez-faire," said Nakamura. "Providers here use technology and branding to justify price increases in ways that simply wouldn’t fly in other nations."

For example, a standard MRI scan costs approximately $1,430 in the U.S., compared to $450 in the Netherlands and $150 in Japan. This discrepancy stems not from differences in technology but from how each system governs usage.

Regulating providers remains politically contentious due to lobbying power. In 2022, the American Medical Association and the Federation of American Hospitals spent over $60 million on political advocacy. "Regional monopolies are a structural issue," Keller said, "but tackling them requires congressional courage that has been conspicuously absent."

Without serious reform, costs will continue to outpace income growth for middle-class families, deepening inequities. As Nakamura put it, "If you can’t afford to get sick, what’s the point of having health care at all?"

The next opportunity for substantial reform may arise after the 2024 presidential election, when both parties will have to confront soaring health care costs as a campaign issue. Until then, the primary drivers—provider pricing—remain unaddressed. The direction of the system depends on whether policymakers heed the accumulating evidence in reports, journals, and patient bank accounts.